Department of Pharmacology, KYDSCT's College of Pharmacy, Sakegaon, Bhusawal 425201, Maharashtra, India; Department of Pharmacology, School of Pharmacy, RK University, Bhavnagar Highway, Kasturbadham, Rajkot 360020, Gujarat, India.
Department of Pharmacology, School of Pharmacy, RK University, Bhavnagar Highway, Kasturbadham, Rajkot 360020, Gujarat, India.
Biomed Pharmacother. 2017 May;89:1353-1361. doi: 10.1016/j.biopha.2017.02.079. Epub 2017 Mar 18.
The present study deals with the investigation of iron chelating and antioxidant potential of Epilobium hirsutum in iron-overloaded rats. Iron overload was induced by 6 IP injections of Iron dextran (12.5mg/100g) administered uniformly over a period of 30 days. Different fractions of E. hirsutum were given orally and deferoxamine (DFO) subcutaneously for 30 days. The extent of iron chelation and various biochemical parameters were estimated on 15th and 30th day of treatment. In-vitro study was assessed by EDTA and DFO method; the results exhibited a dose-dependant iron chelation. The methanolic fraction of methanolic extract (MFME) and methanolic fraction of aqueous extract (MFAE) of E. hirsutum showed significant (p<0.01) iron chelating and antioxidant potential as compared to disease control (DC) rats. The animals treated with MFME and MFAE of E. hirsutum showed significant (p<0.01) vital organ protection as compared to DC rats. The animals treated for longer duration (30th day) reveals better iron chelation potential than shorter ones (15th day). Superior iron chelation was seen at higher dose (300mg/kg) as compared to lower dose (150mg/kg). Taken into an account, our result reveals the reversible iron chelating and antioxidant ability of E. hirsutum and gives some evidence for its possible mechanism via excretion of iron in urine and feces.
本研究旨在探讨粗糙滨藜对铁过载大鼠的螯合铁和抗氧化潜力。铁过载通过 6 次腹腔注射给予铁葡聚糖(12.5mg/100g)诱导,在 30 天内均匀给药。不同的粗糙滨藜提取物以口服和去铁胺(DFO)皮下给药的方式进行 30 天的治疗。在第 15 天和第 30 天治疗期间,评估铁螯合和各种生化参数。在体外研究中,采用 EDTA 和 DFO 法进行评估,结果显示出剂量依赖性的铁螯合作用。粗糙滨藜的甲醇提取物的甲醇部分(MFME)和水提取物的甲醇部分(MFAE)与疾病对照组(DC)大鼠相比,显示出显著(p<0.01)的铁螯合和抗氧化潜力。与 DC 大鼠相比,用 MFME 和 MFAE 治疗的动物显示出显著(p<0.01)的重要器官保护作用。与较短的治疗时间(第 15 天)相比,较长时间(第 30 天)的治疗显示出更好的铁螯合潜力。与较低剂量(150mg/kg)相比,较高剂量(300mg/kg)的铁螯合作用更好。综上所述,我们的结果揭示了粗糙滨藜的可逆铁螯合和抗氧化能力,并为其通过尿液和粪便中铁的排泄可能的机制提供了一些证据。